HealthCare Global Enterprises (HCG) has inaugurated a new 132‑bed comprehensive cancer care hospital in Hebbal/North Bengaluru, marking its third oncology facility in the city and expanding its network across Karnataka and India.
Scale and investment
The new Bengaluru facility represents a total investment of approximately ₹129 crore, funded through a mix of debt and internal accruals.
The 132‑bed hospital is designed to provide full‑spectrum oncology services, from high‑precision diagnosis and surgery to chemotherapy, specialized radiation therapy and recovery support.
Technology and clinical focus
A key highlight of the centre is Karnataka’s first Elekta Unity MR‑LINAC (Magnetic Resonance‑Linear Accelerator), which integrates MRI imaging with radiotherapy to deliver more precise, real‑time‑guided radiation treatment.
The setup aims to improve clinical outcomes, reduce side effects and shorten treatment duration, particularly for complex tumours in the brain, abdomen and other challenging sites.
Strategic positioning in Bengaluru
Located in Hebbal/Byatarayanapura in North Bengaluru, the hospital targets fast‑growing residential and semi‑urban corridors where demand for advanced cancer care is rising.
With this launch, HCG now operates three dedicated cancer centres in Bengaluru, strengthening its footprint in one of India’s key medical‑services hubs and giving patients access to a unified network of specialists and protocols.
Broader network and growth outlook
The Bengaluru facility is part of HCG’s broader expansion plan, which includes multiple state‑of‑the‑art cancer centres across India and Africa.
The ₹129‑crore investment underscores the company’s focus on capital‑intensive, technology‑driven oncology infrastructure aimed at improving access, quality and outcomes in high‑growth urban and peri‑urban markets.
